Current and historical daily PE Ratio for Bioton (
LTS:0DTR
) from 2007 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bioton stock (LTS:0DTR) PE ratio as of Jun 10 2024 is 0.
More Details
Bioton SA (LTS:0DTR) PE Ratio (TTM) Chart
Bioton SA (LTS:0DTR) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1290
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Bioton PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | At Loss | 2024-04-08 | At Loss |
| 2024-06-07 | At Loss | 2024-04-05 | At Loss |
| 2024-06-06 | At Loss | 2024-04-04 | At Loss |
| 2024-06-05 | At Loss | 2024-04-03 | At Loss |
| 2024-06-04 | At Loss | 2024-04-02 | At Loss |
| 2024-06-03 | At Loss | 2024-04-01 | At Loss |
| 2024-05-31 | At Loss | 2024-03-29 | At Loss |
| 2024-05-30 | At Loss | 2024-03-28 | At Loss |
| 2024-05-29 | At Loss | 2024-03-27 | 98.0 |
| 2024-05-28 | At Loss | 2024-03-26 | 98.0 |
| 2024-05-27 | At Loss | 2024-03-25 | 98.0 |
| 2024-05-24 | At Loss | 2024-03-22 | 98.0 |
| 2024-05-23 | At Loss | 2024-03-21 | 98.0 |
| 2024-05-22 | At Loss | 2024-03-20 | 98.0 |
| 2024-05-21 | At Loss | 2024-03-19 | 98.0 |
| 2024-05-20 | At Loss | 2024-03-18 | 98.0 |
| 2024-05-17 | At Loss | 2024-03-15 | 98.0 |
| 2024-05-16 | At Loss | 2024-03-14 | 98.0 |
| 2024-05-15 | At Loss | 2024-03-13 | 98.0 |
| 2024-05-14 | At Loss | 2024-03-12 | 98.0 |
| 2024-05-13 | At Loss | 2024-03-11 | 98.0 |
| 2024-05-10 | At Loss | 2024-03-08 | 98.0 |
| 2024-05-09 | At Loss | 2024-03-07 | 98.0 |
| 2024-05-08 | At Loss | 2024-03-06 | 98.0 |
| 2024-05-07 | At Loss | 2024-03-05 | 98.0 |
| 2024-05-06 | At Loss | 2024-03-04 | 98.0 |
| 2024-05-03 | At Loss | 2024-03-01 | 98.0 |
| 2024-05-02 | At Loss | 2024-02-29 | 98.0 |
| 2024-05-01 | At Loss | 2024-02-28 | 98.0 |
| 2024-04-30 | At Loss | 2024-02-27 | 98.0 |
| 2024-04-29 | At Loss | 2024-02-26 | 98.0 |
| 2024-04-26 | At Loss | 2024-02-23 | 98.0 |
| 2024-04-25 | At Loss | 2024-02-22 | 98.0 |
| 2024-04-24 | At Loss | 2024-02-21 | 98.0 |
| 2024-04-23 | At Loss | 2024-02-20 | 98.0 |
| 2024-04-22 | At Loss | 2024-02-19 | 98.0 |
| 2024-04-19 | At Loss | 2024-02-16 | 98.0 |
| 2024-04-18 | At Loss | 2024-02-15 | 98.0 |
| 2024-04-17 | At Loss | 2024-02-14 | 98.0 |
| 2024-04-16 | At Loss | 2024-02-13 | 98.0 |
| 2024-04-15 | At Loss | 2024-02-12 | 98.0 |
| 2024-04-12 | At Loss | 2024-02-09 | 98.0 |
| 2024-04-11 | At Loss | 2024-02-08 | 98.0 |
| 2024-04-10 | At Loss | 2024-02-07 | 98.0 |
| 2024-04-09 | At Loss | 2024-02-06 | 98.0 |
Bioton SA (LTS:0DTR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Bioton SA
ISIN : PLBIOTN00029
Compare
Compare
Traded in other countries / regions
BIO.Poland7U5.Germany0DTR.UK IPO Date
2007-10-27Description
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers